• PDF

    Final published version, 498 KB, PDF-document

    Request copy


  • Y. Schmidt
  • M. van der Voort
  • M. Crüsemann
  • J. Piel
  • M. Josten
  • H.-G. Sahl
  • H. Miess
  • J.M. Raaijmakers
  • H. Gross
Within the framework of our genome-based program to discover new antibiotic lipopeptides from Pseudomonads, brabantamides A–C were isolated from plant-associated Pseudomonas sp. SH-C52. Brabantamides A–C displayed moderate to high in vitro activities against Gram-positive bacterial pathogens. Their shared structure is unique in that they contain a 5,5-bicyclic carbamate scaffold. Here, the biosynthesis of brabantamide A (SB-253514) was studied by a combination of bioinformatics, feeding experiments with isotopically labelled precursors and in vivo and in vitro functional analysis of enzymes encoded in the biosynthetic pathway. The studies resulted in the deduction of all biosynthetic building blocks of brabantamide A and revealed an unusual feature of this metabolite: its biosynthesis occurs via an initially formed linear di-lipopeptide that is subsequently rearranged by a novel FAD-dependent Baeyer–Villiger monooxygenase. [KEYWORDS: biosynthesis carbamates monooxygenases peptides Pseudomonas SB-253514]
Original languageEnglish
Pages (from-to)259-266
Issue number2
Publication statusPublished - 2014

    Research areas

  • international

ID: 180348